(Q55315506)

English

Effect of combination therapy with matrix metalloproteinase inhibitor MMI-166 and mitomycin C on the growth and liver metastasis of human colon cancer.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

1 July 2018

http://europepmc.org/abstract/PMC/5926761

Effect of combination therapy with matrix metalloproteinase inhibitor MMI-166 and mitomycin C on the growth and liver metastasis of human colon cancer. (English)

1 reference

Europe PubMed Central

PMC publication ID

1 July 2018

http://europepmc.org/abstract/PMC/5926761

liver metastasis

1 reference

based on heuristic

inferred from title

author name string

M Ohta

1

1 reference

Europe PubMed Central

PMC publication ID

1 July 2018

http://europepmc.org/abstract/PMC/5926761

H Konno

2

1 reference

Europe PubMed Central

PMC publication ID

1 July 2018

http://europepmc.org/abstract/PMC/5926761

T Tanaka

3

1 reference

Europe PubMed Central

PMC publication ID

1 July 2018

http://europepmc.org/abstract/PMC/5926761

M Baba

4

1 reference

Europe PubMed Central

PMC publication ID

1 July 2018

http://europepmc.org/abstract/PMC/5926761

K Kamiya

5

1 reference

Europe PubMed Central

PMC publication ID

1 July 2018

http://europepmc.org/abstract/PMC/5926761

K Oba

6

1 reference

Europe PubMed Central

PMC publication ID

1 July 2018

http://europepmc.org/abstract/PMC/5926761

T Kaneko

7

1 reference

Europe PubMed Central

PMC publication ID

1 July 2018

http://europepmc.org/abstract/PMC/5926761

T Syouji

8

1 reference

Europe PubMed Central

PMC publication ID

1 July 2018

http://europepmc.org/abstract/PMC/5926761

A Igarashi

9

1 reference

Europe PubMed Central

PMC publication ID

1 July 2018

http://europepmc.org/abstract/PMC/5926761

S Nakamura

10

1 reference

Europe PubMed Central

PMC publication ID

1 July 2018

http://europepmc.org/abstract/PMC/5926761

publication date

1 June 2001

1 reference

Europe PubMed Central

PMC publication ID

1 July 2018

http://europepmc.org/abstract/PMC/5926761

number of pages

8

1 reference

based on heuristic

inferred from page(s)

Japanese Journal of Cancer Research

1 reference

Europe PubMed Central

PMC publication ID

1 July 2018

http://europepmc.org/abstract/PMC/5926761

92

1 reference

Europe PubMed Central

PMC publication ID

1 July 2018

http://europepmc.org/abstract/PMC/5926761

6

1 reference

Europe PubMed Central

PMC publication ID

1 July 2018

http://europepmc.org/abstract/PMC/5926761

688-695

1 reference

Europe PubMed Central

PMC publication ID

1 July 2018

http://europepmc.org/abstract/PMC/5926761

Phase I and pharmacologic study of the specific matrix metalloproteinase inhibitor BAY 12-9566 on a protracted oral daily dosing schedule in patients with solid malignancies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926761

3 July 2018

Inhibition of tumour growth by marimastat in a human xenograft model of gastric cancer: relationship with levels of circulating CEA

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926761

3 July 2018

Marked inhibition of tumor growth in a malignant glioma tumor model by a novel synthetic matrix metalloproteinase inhibitor AG3340.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926761

3 July 2018

Preventive effect of matrix metalloproteinase inhibitor, R-94138, in combination with mitomycin C or cisplatin on peritoneal dissemination of human gastric cancer cell line TMK-1 in nude mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926761

3 July 2018

Results of single and repeat dose studies of the oral matrix metalloproteinase inhibitor marimastat in healthy male volunteers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926761

3 July 2018

Matrix metalloproteinase inhibition as a novel anticancer strategy: a review with special focus on batimastat and marimastat

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926761

3 July 2018

The matrix metalloproteinases and their inhibitors in pancreatic cancer. From molecular science to a clinical application

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926761

3 July 2018

Tissue levels of matrix metalloproteinases MMP-2 and MMP-9 are related to the overall survival of patients with gastric carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926761

3 July 2018

Expression of most matrix metalloproteinase family members in breast cancer represents a tumor-induced host response.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926761

3 July 2018

Tumor invasion and metastases--role of the extracellular matrix: Rhoads Memorial Award lecture.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926761

3 July 2018

H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metalloprotease capable of degrading basement membrane collagen

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926761

3 July 2018

Localization of messenger RNA for Mr 72,000 and 92,000 type IV collagenases in human skin cancers by in situ hybridization

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926761

3 July 2018

Combination therapy with vascular endothelial growth factor neutralizing antibody and mitomycin C on human gastric cancer xenograft.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926761

12 August 2018

Antitumor effect on human gastric cancer and induction of apoptosis by vascular endothelial growth factor neutralizing antibody.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926761

12 August 2018

Expression of type IV collagenase correlates with the expression of vascular endothelial growth factor in primary non-small cell lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926761

12 August 2018

Combined analysis of studies of the effects of the matrix metalloproteinase inhibitor marimastat on serum tumor markers in advanced cancer: selection of a biologically active and tolerable dose for longer-term studies.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926761

12 August 2018

Type IV collagenase(s) and TIMPs modulate endothelial cell morphogenesis in vitro.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926761

12 August 2018

Fas-mediated apoptosis in Ewing's sarcoma cell lines by metalloproteinase inhibitors

1 reference

https://pubmed.ncbi.nlm.nih.gov/11429059

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of gelatinase A (MMP-2) by batimastat and captopril reduces tumor growth and lung metastases in mice bearing Lewis lung carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/11429059

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Correlation of antiangiogenic and antitumor efficacy of N-biphenyl sulfonyl-phenylalanine hydroxiamic acid (BPHA), an orally-active, selective matrix metalloproteinase inhibitor

1 reference

https://pubmed.ncbi.nlm.nih.gov/11429059

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I/II trial of batimastat, a matrix metalloproteinase inhibitor, in patients with malignant ascites

1 reference

https://pubmed.ncbi.nlm.nih.gov/11429059

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relationship between matrix metalloproteinase expression and tumor angiogenesis in human breast carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/11429059

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The matrix metalloproteinase inhibitor batimastat inhibits angiogenesis in liver metastases of B16F1 melanoma cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/11429059

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I trial of a novel matrix metalloproteinase inhibitor batimastat (BB-94) in patients with advanced cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/11429059

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Type IV collagenase (M(r) 72,000) expression in human prostate: benign and malignant tissue

1 reference

https://pubmed.ncbi.nlm.nih.gov/11429059

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A synthetic matrix metalloproteinase inhibitor decreases tumor burden and prolongs survival of mice bearing human ovarian carcinoma xenografts

1 reference

https://pubmed.ncbi.nlm.nih.gov/11429059

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of the inhibitory effect of the angiogenesis inhibitor, TNP-470, and mitomycin C on the growth and liver metastasis of human colon cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/11429059

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of organ invasion by the matrix metalloproteinase inhibitor batimastat (BB-94) in two human colon carcinoma metastasis models

1 reference

https://pubmed.ncbi.nlm.nih.gov/11429059

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anti-tumor and anti-metastatic effects of human-vascular-endothelial-growth-factor-neutralizing antibody on human colon and gastric carcinoma xenotransplanted orthotopically into nude mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/11429059

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Controlling tumor angiogenesis and metastasis of C26 murine colon adenocarcinoma by a new matrix metalloproteinase inhibitor, KB-R7785, in two tumor models

1 reference

https://pubmed.ncbi.nlm.nih.gov/11429059

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduced angiogenesis and tumor progression in gelatinase A-deficient mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/11429059

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of matrix metalloproteinase inhibitor batimastat on breast cancer regrowth and metastasis in athymic mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/11429059

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination therapy including a gelatinase inhibitor and cytotoxic agent reduces local invasion and metastasis of murine Lewis lung carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/11429059

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Control of lymphatic and hematogenous metastasis of a rat mammary carcinoma by the matrix metalloproteinase inhibitor batimastat (BB-94)

1 reference

https://pubmed.ncbi.nlm.nih.gov/11429059

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevention of hepatic metastasis of human colon cancer by angiogenesis inhibitor TNP-470

1 reference

https://pubmed.ncbi.nlm.nih.gov/11429059

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of the metastatic spread and growth of B16-BL6 murine melanoma by a synthetic matrix metalloproteinase inhibitor

1 reference

https://pubmed.ncbi.nlm.nih.gov/11429059

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interferon gamma induces cell cycle arrest and apoptosis in a model of ovarian cancer: Enhancement of effect by batimastat

1 reference

https://pubmed.ncbi.nlm.nih.gov/11429059

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Batimastat, a synthetic inhibitor of matrix metalloproteinases, potentiates the antitumor activity of cisplatin in ovarian carcinoma xenografts

1 reference

https://pubmed.ncbi.nlm.nih.gov/11429059

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of Angiogenesis and Murine Hemangioma Growth by Batimastat, a Synthetic Inhibitor of Matrix Metalloproteinases

1 reference

https://pubmed.ncbi.nlm.nih.gov/11429059

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1111/J.1349-7006.2001.TB01149.X

1 reference

Europe PubMed Central

PMC publication ID

1 July 2018

http://europepmc.org/abstract/PMC/5926761

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

1 July 2018

http://europepmc.org/abstract/PMC/5926761

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

1 July 2018

http://europepmc.org/abstract/PMC/5926761

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q55315506&oldid=1770260550"